Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

May 15, 2020

Conditions
Chronic Kidney Disease
Interventions
DRUG

Micro-particle Curcumin

as described in Arm

DRUG

Placebo

Looks, smells, tastes and feels exactly like the Curcumin capsules.

Trial Locations (4)

L8L 0A6

Population Health Research Institute, Hamilton

N6A 5A5

Kidney Clinical Care Unit, London

University Hospital, London

N6A 5W9

Victoria Hospital, London

All Listed Sponsors
collaborator

The Kidney Foundation of Canada

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease | Biotech Hunter | Biotech Hunter